🇺🇸 FDA
Pipeline program

Intracoronary infusion of autologous bone marrow cells

TCMR0007/2006

Phase 2 other completed

Quick answer

Intracoronary infusion of autologous bone marrow cells for Dilated Cardiomyopathy is a Phase 2 program (other) at Design Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Design Therapeutics
Indication
Dilated Cardiomyopathy
Phase
Phase 2
Modality
other
Status
completed

Clinical trials